Literature DB >> 7045414

Intravenous digital subtraction angiography in brain ischemia.

J R Little, A J Furlan, M T Modic, B Bryerton, M A Weinstein.   

Abstract

Recent advances in computer and radiological technology have permitted a reassessment of intravenous (IV) angiography in the evaluation of extracranial and intracranial vessels. This report reviews our initial experience with IV digital subtraction angiography in the diagnosis and treatment of brain ischemia. Two hundred seventy-three IV digital subtraction angiograms (146 extracranial, 127 intracranial) were performed on a total of 178 patients with suspected cerebral ischemia (159 patients), brainstem/cerebellar ischemia (13 patients), or asymptomatic bruit (six patients). Extracranial studies clearly demonstrated ulceration, stenosis, and occlusion of the carotid arteries. Intracranial studies usually detected major artery occlusive disease and provided insight into the collateral flow patterns. Intravenous digital subtraction angiography allowed the accurate assessment of arteries after carotid endarterectomy and brain bypass surgery. Although conventional angiography was usually recommend in patients treated surgically, IV digital subtraction angiography obviated the need for conventional studies in the initial evaluation of many patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7045414

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Carotid Doppler evaluation in cerebrovascular disease.

Authors:  J G D'Alton; J W Norris
Journal:  Can Med Assoc J       Date:  1983-12-01       Impact factor: 8.262

2.  Digital subtraction angiography in patients with cerebral ischaemic attacks and normal continuous wave Doppler studies.

Authors:  M Guidotti; G Landi; G Scotti; G Scarlato
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

Review 3.  Transient cerebral ischemia.

Authors:  M D Cusimano; F M Ameli
Journal:  CMAJ       Date:  1989-01-01       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.